Mahidol Launches 15-Minute Melioidosis Rapid Test with 95% Accuracy, Aiming to Tackle Thailand’s Rising "Soil Fever" Threat

With Melioidosis (Soil Fever) cases on the rise and a growing number of fatalities reported across Thailand, the nation’s public health system is facing a critical challenge in managing this "silent killer." Often misdiagnosed or detected too late, the infection requires urgent intervention.

In a major healthcare breakthrough, a research team from Mahidol University has developed the MUTM Melioidosis Antibody Test. This innovative rapid test kit delivers results within 15 minutes with over 95% accuracy. The university has announced its readiness to distribute the kits to hospitals nationwide, directly addressing the primary cause of mortality: delayed diagnosis.

What is Melioidosis? 

Melioidosis is caused by the bacterium Burkholderia pseudomallei, commonly found in soil and water—particularly in agricultural areas like rice paddies.

The danger lies in its symptoms; in the early stages, it often mimics a common flu, leading many patients to seek treatment only when the condition has become severe. This delay significantly increases the risk of complications and death. 

Currently, the disease is seeing a spike in cases among farmers and those in frequent contact with soil. Health officials advise that anyone experiencing a high fever for more than two days, chills, fatigue, or infected wounds should seek medical attention immediately and disclose their exposure history.

The Critical Time Trap 

Prof. Dr. Narisara Chantratita of The Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, emphasizes that the biggest hurdle isn't just the severity of the bacteria, but the time gap between testing and survival.

Critical patients can succumb to the infection within the first 48 hours, yet standard bacterial culture methods typically take 3 to 7 days. This means many patients do not receive the correct antibiotics in time.

"Many cases simply cannot afford to wait for lab results. This is the critical gap that leads to loss of life," says Prof. Dr. Narisara 

15 Minutes to Save Lives

95% Accuracy To close this gap, the research team developed the MUTM Melioidosis Antibody Test. Key features include:

• Speed: Results in 10–15 minutes.
• Precision: Over 95% accuracy for preliminary screening.
• Early Intervention: Allows physicians to prescribe specific antibiotics immediately before symptoms escalate.

In the fight against Melioidosis, speed is not just a convenience—it is the difference between life and death.

Decentralized Diagnostics

Reaching Community Hospitals This innovation marks a significant shift toward Decentralized Diagnostics. Prof. Dr. Narisara points out that the kit enables community hospitals to perform on-site testing without the need to send samples to major centers.

This ensures that citizens in remote areas have access to the same diagnostic standards as those in major cities. "We aren't just creating a test kit; we are creating healthcare equity," she added.

Mahidol x Sierra: Ready for Commercial Scale

The MUTM Melioidosis Antibody Test is now officially ready for medical use. It is available for order by public and private hospitals, clinics, and health units nationwide. The production and distribution are managed through a strategic partnership between Mahidol University and Sierra.

The product is launched under the "Mahidol Collection"—a brand certifying innovations from the university. The project was propelled into the commercial market by the Institute for Technology and Innovation Management (INT) at Mahidol University, acting as an "Innovation Gateway" to connect academic research with the private sector for large-scale social impact.